deferiprone has been researched along with Cardiomyopathy, Congestive in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Iron overload is one of the major causes of morbidity and death in patients undergoing chronic transfusion therapy." | 2.48 | Iron chelation therapy in the management of transfusion-related cardiac iron overload. ( Fernandes, JL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, JL | 1 |
| Porcu, M | 1 |
| Landis, N | 1 |
| Salis, S | 1 |
| Corda, M | 1 |
| Orrù, P | 1 |
| Serra, E | 1 |
| Usai, B | 1 |
| Matta, G | 1 |
| Galanello, R | 1 |
1 review available for deferiprone and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Iron chelation therapy in the management of transfusion-related cardiac iron overload.
Topics: Benzoates; Cardiomyopathy, Dilated; Chelation Therapy; Cross-Sectional Studies; Deferasirox; Deferip | 2012 |
1 other study available for deferiprone and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Effects of combined deferiprone and desferrioxamine iron chelating therapy in beta-thalassemia major end-stage heart failure: a case report.
Topics: Adult; beta-Thalassemia; Cardiomyopathy, Dilated; Deferiprone; Deferoxamine; Drug Therapy, Combinati | 2007 |